HomeMYND • CNSX
add
MYND Life Sciences Inc
Previous close
$0.030
Year range
$0.0050 - $0.10
Market cap
730.76K CAD
Avg Volume
6.58K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 269.14K | -52.33% |
Net income | -372.76K | 55.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -333.78K | 48.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 265.00 | — |
Total assets | 771.35K | 40.56% |
Total liabilities | 6.12M | 24.43% |
Total equity | -5.35M | — |
Shares outstanding | 47.82M | — |
Price to book | -0.27 | — |
Return on assets | -106.58% | — |
Return on capital | 38.64% | — |
Cash Flow
Net change in cash
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -372.76K | 55.54% |
Cash from operations | -38.32K | -376.57% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -38.32K | -3,252.93% |
Free cash flow | 139.79K | -19.86% |
About
Founded
2018
Headquarters
Website
Employees
10